BCL2 and breast carcinoma: The role of pro-apoptotic hsa-miR-195 in inhibiting de novo lipogenesis via targeting genes overexpressed in breast cancer (BCL-2, FASN, ACACA, HMGCR, CYP27B1) makes hsa-miR-195 an effective anticancer molecule.